AKASA

AKASA builds generative AI solutions for the healthcare revenue cycle, applying large language models and machine learning to automate complex administrative workflows in hospitals and health systems. The company was founded in 2018 and is headquartered in South San Francisco, California.

The company's flagship product, the AKASA generative AI revenue cycle platform, combines proprietary generative AI technology with revenue cycle expertise to handle prior authorization, clinical documentation improvement (CDI), medical coding and claims management. A distinguishing feature of the approach is that the platform trains large language models on each health system's own clinical and financial data, rather than relying solely on generic pre-trained models. Relevant technical domains include generative AI, LLMs, machine learning, healthcare data modeling, workflow automation and natural language processing.

AKASA reports that it serves more than 650 hospitals and 6,500 outpatient facilities across all 50 US states, and has raised over $205 million in funding. Its stated mission is to build the future of healthcare with AI, helping health systems improve revenue outcomes and free resources for patient care.